JIA-HORNG KAO2021-09-042021-09-0420020815-9319https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036227503&doi=10.1046%2fj.1440-1746.2002.02623.x&partnerID=40&md5=74ae1d502574060b74e6fff69348beedhttps://scholars.lib.ntu.edu.tw/handle/123456789/582263[SDGs]SDG3hepatitis B(e) antigen; interferon; nuclear factor I; nucleotide; protein X; ribavirin; antigen recognition; base pairing; clinical feature; disease course; disease severity; editorial; gene mutation; genotype; hepatitis B; Hepatitis B virus; Hepatitis C virus; Hepatitis delta virus; human; pathogenesis; priority journal; seroconversion; virus cell interaction; virus replicationeditorial10.1046/j.1440-1746.2002.02623.x2-s2.0-0036227503